Author:
Vlaar Judith M.,Borgman Anouska,Kalkhoven Eric,Westland Denise,Besselink Nicolle,Shale Charles,Faltas Bishoy M.,Priestley Peter,Kuijk Ewart,Cuppen Edwin
Abstract
AbstractBladder cancer has a high recurrence rate and low survival of advanced stage patients. Few genetic drivers of bladder cancer have thus far been identified. We performed in-depth structural variant analysis on whole-genome sequencing data of 206 metastasized urinary tract cancers. In ~ 10% of the patients, we identified recurrent in-frame deletions of exons 8 and 9 in the aryl hydrocarbon receptor gene (AHRΔe8-9), which codes for a ligand-activated transcription factor. Pan-cancer analyses show that AHRΔe8-9 is highly specific to urinary tract cancer and mutually exclusive with other bladder cancer drivers. The ligand-binding domain of the AHRΔe8-9 protein is disrupted and we show that this results in ligand-independent AHR-pathway activation. In bladder organoids, AHRΔe8-9 induces a transformed phenotype that is characterized by upregulation of AHR target genes, downregulation of differentiation markers and upregulation of genes associated with stemness and urothelial cancer. Furthermore, AHRΔe8-9 expression results in anchorage independent growth of bladder organoids, indicating tumorigenic potential. DNA-binding deficient AHRΔe8-9 fails to induce transformation, suggesting a role for AHR target genes in the acquisition of the oncogenic phenotype. In conclusion, we show that AHRΔe8-9 is a novel driver of urinary tract cancer and that the AHR pathway could be an interesting therapeutic target.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. American Cancer Society. Cancer Facts and Figures 2020 (American Cancer Society, 2020).
2. James, A. C. & Gore, J. L. The costs of non-muscle invasive bladder cancer. Urol. Clin. N. Am. 40, 261–269 (2013).
3. Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder cancer: A review. JAMA 324, 1980–1991 (2020).
4. Loriot, Y. et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N. Engl. J. Med. 381, 338–348 (2019).
5. Berdik, C. Unlocking bladder cancer. Nature 551, S34–S35 (2017).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献